BioRem (CVE:BRM) Shares Up 16% – Should You Buy?

BioRem Inc. (CVE:BRM) shares were up 16% on Wednesday. The stock traded as high as C$4.41 and last traded at C$4.35. Approximately 100,846 shares changed hands during trading, an increase of 339% from the average daily volume of 22,966 shares. The stock had previously closed at C$3.75.

BioRem Stock Down 2.8%

The stock’s fifty day moving average price is C$3.61 and its 200-day moving average price is C$3.13. The company has a quick ratio of 1.08, a current ratio of 2.04 and a debt-to-equity ratio of 14.17. The company has a market capitalization of C$68.07 million, a price-to-earnings ratio of 12.50 and a beta of 0.78.

Insiders Place Their Bets

In other BioRem news, Director Derek Webb sold 28,700 shares of the company’s stock in a transaction dated Monday, August 24th. The shares were sold at an average price of C$3.82, for a total transaction of C$109,634.00. Following the transaction, the director owned 362,370 shares in the company, valued at approximately C$1,384,253.40. This represents a 7.34% decrease in their position. Company insiders own 1.90% of the company’s stock.

BioRem Company Profile

BioRem Inc, a clean technology engineering company, designs, manufactures, distributes, and sells air pollution control systems that are used to eliminate odors, volatile organic compounds (VOCs), and hazardous air pollutants (HAPs). It offers biofilters for the removal of odors, H2S, VOCs, and HAPs; and biotrickling filters for applications of high levels of H2S or other water-soluble VOCs. The company also provides multi-stage systems to remove odors from various municipal/urban wastewater treatment processes; biogas desulfurization systems; dry scrubber adsorption systems; and cannabis odor control systems.